Testing vilazodone for post-traumatic stress disorder
Part of Mental health clinical trials.
This study is testing whether a medicine called vilazodone (also known as Viibryd) can help reduce PTSD symptoms. It's part of a larger ongoing study that adapts based on what's working, so you'd be helping find better treatments for PTSD.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have post-traumatic stress disorder (PTSD) as described in the main study rules.
- You have not already tried vilazodone for PTSD for 4 weeks or longer.
- You must meet all the general health and safety requirements listed in the main study (NCT05422612).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medication, TSND-201, to see if it is safe and effective for people living with PTSD. It is for adults who have already tried at least one other treatment and are looking for a new option.
This study tests whether a stimulant medication can help reduce PTSD symptoms. If you have PTSD and are generally healthy, you might be able to join.
This Phase 2 trial studies pimavanserin, a medicine meant to improve insomnia, in veterans who also have PTSD. It may help reduce problems with falling asleep, staying asleep, or waking too early that affect daytime functioning.
This Phase 2 trial tests whether therapy assisted by MDMA can reduce symptoms of moderate to severe post-traumatic stress disorder (PTSD) in eligible veterans. It includes supervised therapy sessions and extra study visits with video recording to track changes over time.
This trial tests if an investigational drug called TSND-201 can help treat PTSD. It is for people who have tried at least one other PTSD treatment before.
This study tests a non-invasive device that stimulates the vagus nerve (a major nerve in your neck) to help reduce PTSD symptoms. The device is worn on the skin and may help ease trauma-related stress and anxiety.
Hear when a new PTSD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.